MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2013.

NCT00093821 | COMPLETED | PHASE1
70 participants

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2004-09-30
Completion:
2007-08-31
Conditions
  • Childhood Chronic Myelogenous Leukemia
  • Childhood Desmoplastic Small Round Cell Tumor
  • Disseminated Neuroblastoma
  • Metastatic Childhood Soft Tissue Sarcoma
  • Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Metastatic Osteosarcoma
  • Previously Treated Childhood Rhabdomyosarcoma
  • Recurrent Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood Acute Myeloid Leukemia
  • Recurrent Childhood Rhabdomyosarcoma
  • Recurrent Childhood Soft Tissue Sarcoma
  • Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Recurrent Neuroblastoma
  • Recurrent Osteosarcoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00084604 | COMPLETED | PHASE2
47 participants

Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2004-04-30
Completion:
2007-10-31
Conditions
  • Adenocarcinoma of the Gastroesophageal Junction
  • Diffuse Adenocarcinoma of the Stomach
  • Intestinal Adenocarcinoma of the Stomach
  • Mixed Adenocarcinoma of the Stomach
  • Recurrent Gastric Cancer
  • Stage IIIA Gastric Cancer
  • Stage IIIB Gastric Cancer
  • Stage IIIC Gastric Cancer
  • Stage IV Gastric Cancer
Interventions
  • DRUG
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
NCT00084461 | TERMINATED | PHASE2
25 participants

Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2004-03-31
Completion:
2004-10-31
Conditions
  • Gastrinoma
  • Glucagonoma
  • Insulinoma
  • Metastatic Gastrointestinal Carcinoid Tumor
  • Pancreatic Polypeptide Tumor
  • Pulmonary Carcinoid Tumor
  • Recurrent Gastrointestinal Carcinoid Tumor
  • Recurrent Islet Cell Carcinoma
  • Regional Gastrointestinal Carcinoid Tumor
  • Somatostatinoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00079131 | COMPLETED | PHASE2
37 participants

Oblimersen in Treating Patients With Merkel Cell Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2004-01-31
Completion:
2007-01-31
Conditions
  • Recurrent Neuroendocrine Carcinoma of the Skin
  • Stage I Neuroendocrine Carcinoma of the Skin
  • Stage II Neuroendocrine Carcinoma of the Skin
  • Stage III Neuroendocrine Carcinoma of the Skin
  • Stage IV Neuroendocrine Carcinoma of the Skin
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT00075439 | COMPLETED | PHASE2
90 participants

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2003-12-31
Completion:
2007-05-31
Conditions
  • Gastrinoma
  • Glucagonoma
  • Insulinoma
  • Metastatic Gastrointestinal Carcinoid Tumor
  • Pancreatic Polypeptide Tumor
  • Recurrent Gastrointestinal Carcinoid Tumor
  • Recurrent Islet Cell Carcinoma
  • Somatostatinoma
  • WDHA Syndrome
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00070551 | COMPLETED | PHASE1
51 participants

GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2003-09-30
Completion:
2009-02-28
Conditions
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
  • Recurrent Adult Acute Myeloid Leukemia
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
No Results Yet
NCT00058227 | COMPLETED | PHASE1
37 participants

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2003-04-30
Completion:
2009-02-28
Conditions
  • B-cell Chronic Lymphocytic Leukemia
  • Contiguous Stage II Grade 1 Follicular Lymphoma
  • Contiguous Stage II Grade 2 Follicular Lymphoma
  • Contiguous Stage II Mantle Cell Lymphoma
  • Contiguous Stage II Marginal Zone Lymphoma
  • Contiguous Stage II Small Lymphocytic Lymphoma
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Nodal Marginal Zone B-cell Lymphoma
  • Noncontiguous Stage II Grade 1 Follicular Lymphoma
  • Noncontiguous Stage II Grade 2 Follicular Lymphoma
  • Noncontiguous Stage II Mantle Cell Lymphoma
  • Noncontiguous Stage II Marginal Zone Lymphoma
  • Noncontiguous Stage II Small Lymphocytic Lymphoma
  • Progressive Hairy Cell Leukemia, Initial Treatment
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Hairy Cell Leukemia
  • Splenic Marginal Zone Lymphoma
  • Stage I Chronic Lymphocytic Leukemia
  • Stage I Grade 1 Follicular Lymphoma
  • Stage I Grade 2 Follicular Lymphoma
  • Stage I Mantle Cell Lymphoma
  • Stage I Marginal Zone Lymphoma
  • Stage I Small Lymphocytic Lymphoma
  • Stage II Chronic Lymphocytic Leukemia
  • Stage III Chronic Lymphocytic Leukemia
  • Stage III Grade 1 Follicular Lymphoma
  • Stage III Grade 2 Follicular Lymphoma
  • Stage III Mantle Cell Lymphoma
  • Stage III Marginal Zone Lymphoma
  • Stage III Small Lymphocytic Lymphoma
  • Stage IV Chronic Lymphocytic Leukemia
  • Stage IV Grade 1 Follicular Lymphoma
  • Stage IV Grade 2 Follicular Lymphoma
  • Stage IV Mantle Cell Lymphoma
  • Stage IV Marginal Zone Lymphoma
  • Stage IV Small Lymphocytic Lymphoma
  • Untreated Hairy Cell Leukemia
  • Waldenström Macroglobulinemia
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT00033462 | COMPLETED | PHASE2
78 participants

Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2002-03-31
Completion:
2006-11-30
Conditions
  • Adult Primary Cholangiocellular Carcinoma
  • Adult Primary Hepatocellular Carcinoma
  • Advanced Adult Primary Liver Cancer
  • Cholangiocarcinoma of the Extrahepatic Bile Duct
  • Cholangiocarcinoma of the Gallbladder
  • Localized Unresectable Adult Primary Liver Cancer
  • Recurrent Adult Primary Liver Cancer
  • Recurrent Extrahepatic Bile Duct Cancer
  • Recurrent Gallbladder Cancer
  • Unresectable Extrahepatic Bile Duct Cancer
  • Unresectable Gallbladder Cancer
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00028535 | COMPLETED | PHASE1
18 participants

Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2001-11-30
Completion:
2009-02-28
Conditions
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Recurrent Endometrial Carcinoma
  • Recurrent Gastric Cancer
  • Recurrent Non-small Cell Lung Cancer
  • Recurrent Ovarian Epithelial Cancer
  • Recurrent Small Cell Lung Cancer
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT00017472 | COMPLETED | PHASE1
35 participants

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2001-04-30
Completion:
2006-04-30
Conditions
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Nodal Marginal Zone B-cell Lymphoma
  • Noncontiguous Stage II Marginal Zone Lymphoma
  • Noncontiguous Stage II Small Lymphocytic Lymphoma
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Splenic Marginal Zone Lymphoma
  • Stage III Marginal Zone Lymphoma
  • Stage III Small Lymphocytic Lymphoma
  • Stage IV Marginal Zone Lymphoma
  • Stage IV Small Lymphocytic Lymphoma
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT00009867 | COMPLETED | PHASE2
35 participants

Arsenic Trioxide in Treating Patients With Urothelial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2000-12-31
Completion:
2004-06-30
Conditions
  • Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Recurrent Urethral Cancer
  • Transitional Cell Carcinoma of the Bladder
  • Ureter Cancer
Interventions
  • DRUG
No Results Yet
NCT00006363 | COMPLETED | PHASE3
720 participants

Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
2000-11-30
Completion:
2005-06-30
Conditions
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia
  • Adult Acute Erythroid Leukemia (M6)
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
  • Adult Acute Monoblastic Leukemia (M5a)
  • Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5)
  • Adult Acute Monocytic Leukemia (M5b)
  • Adult Acute Myeloblastic Leukemia With Maturation (M2)
  • Adult Acute Myeloblastic Leukemia Without Maturation (M1)
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Del(5q)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
  • Adult Acute Myelomonocytic Leukemia (M4)
  • Adult Erythroleukemia (M6a)
  • Adult Pure Erythroid Leukemia (M6b)
  • Childhood Acute Basophilic Leukemia
  • Childhood Acute Eosinophilic Leukemia
  • Childhood Acute Erythroleukemia (M6)
  • Childhood Acute Megakaryocytic Leukemia (M7)
  • Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)
  • Childhood Acute Monoblastic Leukemia (M5a)
  • Childhood Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5)
  • Childhood Acute Monocytic Leukemia (M5b)
  • Childhood Acute Myeloblastic Leukemia With Maturation (M2)
  • Childhood Acute Myeloblastic Leukemia Without Maturation (M1)
  • Childhood Acute Myelomonocytic Leukemia (M4)
  • Childhood Myelodysplastic Syndromes
  • de Novo Myelodysplastic Syndromes
  • Untreated Adult Acute Myeloid Leukemia
  • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Interventions
  • DRUG
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
NCT00003190 | COMPLETED | PHASE3
640 participants

Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-04
Start Date:
1998-01-31
Completion:
2002-08-31
Conditions
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
  • Adult Acute Monoblastic Leukemia (M5a)
  • Adult Acute Monocytic Leukemia (M5b)
  • Adult Acute Myeloblastic Leukemia With Maturation (M2)
  • Adult Acute Myeloblastic Leukemia Without Maturation (M1)
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Del(5q)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
  • Adult Acute Myelomonocytic Leukemia (M4)
  • Adult Erythroleukemia (M6a)
  • Adult Pure Erythroid Leukemia (M6b)
  • Untreated Adult Acute Myeloid Leukemia
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page